Standard Biotools (LAB) Change in Account Payables (2010 - 2026)

Standard Biotools (LAB) has 17 years of Change in Account Payables data on file, last reported at -$1.2 million in Q1 2026.

• On a quarterly basis, Change in Account Payables fell 111.76% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 154.79% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 118.78% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$1.2 million, down from $653000.0 in the prior quarter.
• Over the last five years, Change in Account Payables for LAB reached as high as $2.1 million in Q4 2023 and fell as low as -$10.3 million in Q1 2024.
• Historically, Change in Account Payables has averaged -$760000.0 across 5 years, with a median of -$88000.0 in 2024.
• Across the five-year window, Change in Account Payables slumped 772.13% in 2024 and surged 842.05% in 2025, its largest moves.
• Year by year, Change in Account Payables stood at -$1.3 million in 2022, then jumped by 264.86% to $2.1 million in 2023, then sank by 104.19% to -$88000.0 in 2024, then jumped by 842.05% to $653000.0 in 2025, then plunged by 287.44% to -$1.2 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$1.2 million in Q1 2026, $653000.0 in Q4 2025, and $946000.0 in Q3 2025.